Cosmo Pharmaceuticals
C43.F
#5365
Rank
C$1.54 B
Marketcap
$96.00
Share price
-1.50%
Change (1 day)
58.45%
Change (1 year)

Earnings for Cosmo Pharmaceuticals (C43.F)

Earnings in 2022: C$36.68 Million

According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings are C$0.10 Billion. In 2022 the company made an earning of C$36.68 Million a decrease over its 2021 earnings that were of C$37.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cosmo Pharmaceuticals from 2004 to 2022

Annual earnings

Year Earnings Change
2022C$36.68 M-3.43%
2021C$37.98 M-418.87%
2020-C$11.92 Million-64.28%
2019-C$33.35 Million19.49%
2018-C$27.91 Million-48.67%
2017-C$54.38 Million-234.57%
2016C$40.4 M-89.6%
2015C$0.38 B110.02%
2014C$0.18 B33.75%
2013C$0.13 B177.69%
2012C$49.8 M201.84%
2011C$16.5 M99.1%
2010C$8.28 M-22.14%
2009C$10.64 M-53.08%
2008C$22.68 M7167.3%
2007C$0.31 M-66.41%
2006C$0.92 M-57.18%
2005C$2.17 M-193.84%
2004-C$2.32 Million